Comparison of buprenorphine and methadone in the treatment of opioid dependence.
about
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependencePharmacological therapies for maintenance treatments of opium dependenceBuprenorphine maintenance versus placebo or methadone maintenance for opioid dependenceBuprenorphine maintenance versus placebo or methadone maintenance for opioid dependenceUpdate on the clinical use of buprenorphine: in opioid-related disordersCurrent and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals.Neuropsychological consequences of opiate use.Practical considerations for the clinical use of buprenorphine.Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers.Developing and Implementing a New Prison-Based Buprenorphine Treatment Program.Opioid dependence treatment: options in pharmacotherapy.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.Buprenorphine and naloxone for heroin dependence.Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers.Deep brain stimulation compared with methadone maintenance for the treatment of heroin dependence: a threshold and cost-effectiveness analysis.BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.Buprenorphine: a (relatively) new treatment for opioid dependence.Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study.The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence.Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication.Buprenorphine retention in primary care.Buprenorphine implant for opioid addictionBuprenorphine/naloxone: a review of its use in the treatment of opioid dependence.Understanding polydrug use: review of heroin and cocaine co-use.Buprenorphine tapering schedule and illicit opioid use.Redefining retention: recovery from the patient's perspective.Buprenorphine maintenance program with contracted work/education and low tolerance for non-prescribed drug use: a cohort study of outcome for women and men after seven yearsTiming of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages.The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and WalesLong-term outcomes of office-based buprenorphine/naloxone maintenance therapy.The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clustersEyes wide shut?--A conceptual and empirical critique of methadone maintenance treatment.Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN).A meta-analysis of retention in methadone maintenance by dose and dosing strategy.Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth.Why buprenorphine is so successful in treating opiate addiction in France.Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research.Home buprenorphine/naloxone induction in primary care
P2860
Q24200539-FC090129-8A8F-4A17-8B8B-9332D46ED331Q24201615-ED3B6BC7-3FB8-4692-BD17-C7D29D0CA0DAQ24243180-C57B3B47-6808-41CB-9A2C-C78ED6EBC009Q24248819-6027CCC1-F70D-4A5F-AFCF-86357984B4F6Q26829140-76A6B9DF-9A1D-41AC-AA15-C12DD89B2093Q27692554-F2B7D358-D69C-4418-80C5-E2FF27CFEB0EQ31121479-7D3F732D-96C1-46F6-BE73-F8712B4A069AQ33774853-FC439FF7-6F49-4A6C-BDB6-C24393D6C6D8Q33837577-048EF047-4A9E-4891-B021-6148F7289FA2Q33844064-DEEDEE38-26DD-46A1-89A8-A25165B68CA9Q33868638-CE689F6C-CA03-4C1A-8FB1-B5DA4FB53C97Q33870389-E0C0D84C-A00F-4D6B-8E39-F9C6DCC667B3Q34081656-FB45FDEB-56C9-4EBD-B947-D2691299B7F4Q34108608-4EED9906-5D6D-4A03-930A-30A3366DB994Q34138291-4A0D05E8-897D-4D07-99B9-419D4746B141Q34216585-884D72BC-D40E-44F1-97C6-37DF9715A360Q34277168-D6E02AE0-D35E-42AB-B579-93DAB221DA02Q34357213-6552EEF0-AC2E-496D-92D0-2256D7B1050DQ34365302-A28698CE-B57F-42DF-B3BF-43311388AC99Q34452695-F1E19325-AF51-4637-9732-34A23259357BQ34620483-7F2B8931-8977-47D9-9080-974AA9DCE1C8Q34721038-B1B5D40E-9160-4348-AC61-04997C2A0090Q34724382-24716552-04DC-41B6-A04B-086E3722E0B2Q34820000-98554E7E-D0C2-40BE-9901-8423D37CE873Q34975842-2EFDCC05-1188-4D7F-B57C-6BB1F2ECE3F9Q35030844-C87837D1-3667-4C80-9BFD-E0014B880988Q35147170-17EBC247-71A9-4ED0-829E-7D656E721D54Q35178444-45B36BEA-AC1D-4F3C-9F4B-9D0B9609B857Q35540698-DE435D1E-9096-4A5B-8989-C41C94B543A2Q35577449-D4C5A1A1-0E88-404F-9E8D-09845CFC86EBQ35675636-126D5369-2996-4A6F-B9D0-2F6AA755FFEEQ35687716-CCE721F1-81FF-4C35-ACA1-2754346383A6Q35792939-60C6976C-213B-4EA6-BD22-1AB80EBD765EQ35988623-BAEA0AE8-2035-4001-9A01-51B941FA7FC7Q36628467-9809D8D1-5B9F-4FC2-B5A0-2EF4382AE05EQ36946147-A964A8FC-65C0-4650-9289-70C5AD07C815Q36952763-5496404F-875A-4F19-8FAE-AAD4938FBA01Q36960169-355BB983-EBD1-4791-8CFB-EAA2C72E4D36Q37062538-38CEC2CA-93EB-44FF-BC92-2C664068F6B6Q37067770-892B786A-B04E-4346-9096-F7497C6A0058
P2860
Comparison of buprenorphine and methadone in the treatment of opioid dependence.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Comparison of buprenorphine and methadone in the treatment of opioid dependence.
@en
Comparison of buprenorphine and methadone in the treatment of opioid dependence.
@nl
type
label
Comparison of buprenorphine and methadone in the treatment of opioid dependence.
@en
Comparison of buprenorphine and methadone in the treatment of opioid dependence.
@nl
prefLabel
Comparison of buprenorphine and methadone in the treatment of opioid dependence.
@en
Comparison of buprenorphine and methadone in the treatment of opioid dependence.
@nl
P2093
P356
P1476
Comparison of buprenorphine and methadone in the treatment of opioid dependence.
@en
P2093
Bigelow GE
Liebson IA
Stitzer ML
P304
P356
10.1176/AJP.151.7.1025
P407
P577
1994-07-01T00:00:00Z